Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...] …
Year: 2024
Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
With the hottest weather of the summer and the hottest topics to go with it, the 340B Coalition Summer Conference was one for the record books. Uniting 340B stakeholders from all backgrounds, over 1,500 attendees met in D.C. feeling apprehensive due
…
The Massachusetts Senate on Thursday failed to adopt legislation that would have prohibited pharmacy benefit managers (PBMs) from imposing discriminatory [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Sen. J.D. Vance (R-Ohio), whom former President Donald Trump (R) tapped as his running mate on Monday, is a co-sponsor [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
As I write this, we’re reaching the end of what’s “officially” LGBTQ+ Pride Month. The first Pride marches were held in New York, Los Angeles, and Chicago on June 28, 1970, to commemorate the first
…
Beacon Hill lawmakers are expected to vote Thursday on a proposal that would prohibit pharmacy benefit managers (PBMs) from imposing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...] …